3.1(top 10%)
impact factor
939(top 20%)
papers
23.8K(top 10%)
citations
64(top 10%)
h-index
3.7(top 10%)
impact factor
1.4K
all documents
24.9K
doc citations
108(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1Basics and recent advances in peptide and protein drug deliveryTherapeutic Delivery2013542
2Size matters: gold nanoparticles in targeted cancer drug deliveryTherapeutic Delivery2012502
3Nanoparticle-assisted combination therapies for effective cancer treatmentTherapeutic Delivery2010471
4PLGA: a unique polymer for drug deliveryTherapeutic Delivery2015429
5Challenges and opportunities in dermal/transdermal deliveryTherapeutic Delivery2010428
6mRNA vaccine delivery using lipid nanoparticlesTherapeutic Delivery2016414
7Nanoparticle-mediated hyperthermia in cancer therapyTherapeutic Delivery2011346
8Recent advances in ophthalmic drug deliveryTherapeutic Delivery2010236
9The nasal approach to delivering treatment for brain diseases: an anatomic, physiologic, and delivery technology overviewTherapeutic Delivery2014220
10The shape of things to come: importance of design in nanotechnology for drug deliveryTherapeutic Delivery2012209
11Flip-flop pharmacokinetics – delivering a reversal of disposition: challenges and opportunities during drug developmentTherapeutic Delivery2011194
12Drug delivery to the lungs: challenges and opportunitiesTherapeutic Delivery2017187
13Recent advances in light-responsive on-demand drug-delivery systemsTherapeutic Delivery2017168
14Micro- and nano-motors: the new generation of drug carriersTherapeutic Delivery2018165
15EPR-effect: utilizing size-dependent nanoparticle delivery to solid tumorsTherapeutic Delivery2013164
16Advances in ophthalmic drug deliveryTherapeutic Delivery2014141
17Mechanisms of microbubble-facilitated sonoporation for drug and gene deliveryTherapeutic Delivery2014133
18Cubosomes and hexosomes as versatile platforms for drug deliveryTherapeutic Delivery2015130
19Exosomes and the blood–brain barrier: implications for neurological diseasesTherapeutic Delivery2011129
20Understanding the lipid-digestion processes in the GI tract before designing lipid-based drug-delivery systemsTherapeutic Delivery2012128
21Recent developments in protein and peptide parenteral delivery approachesTherapeutic Delivery2014124
22ROS-activated anticancer prodrugs: a new strategy for tumor-specific damageTherapeutic Delivery2012123
23Therapeutic angiogenesis: controlled delivery of angiogenic factorsTherapeutic Delivery2012121
24pH-sensitive drug-delivery systems for tumor targetingTherapeutic Delivery2013121
25Liposomal formulations for inhalationTherapeutic Delivery2013120
26Nanobubbles: a promising efficienft tool for therapeutic deliveryTherapeutic Delivery2016120
27pH-sensitive liposomes for drug delivery in cancer treatmentTherapeutic Delivery2013119
28Polymersome-based drug-delivery strategies for cancer therapeuticsTherapeutic Delivery2015119
29Oligonucleotide conjugates for therapeutic applicationsTherapeutic Delivery2013117
30Subunit vaccines of the future: the need for safe, customized and optimized particulate delivery systemsTherapeutic Delivery2011116
31Polymeric micelles for anticancer drug deliveryTherapeutic Delivery2020114
32COVID-19 pandemic: an overview of epidemiology, pathogenesis, diagnostics and potential vaccines and therapeuticsTherapeutic Delivery2020113
33Nanogels as drug-delivery systems: a comprehensive overviewTherapeutic Delivery2019109
34Cancer immunotherapy: accomplishments to date and future promiseTherapeutic Delivery2013106
35Challenges in realizing selectivity for nanoparticle biodistribution and clearance: lessons from gold nanoparticlesTherapeutic Delivery2017105
36Advanced drug delivery systems for local treatment of the oral cavityTherapeutic Delivery2015104
37Nanomedicines for cancer therapy: current status, challenges and future prospectsTherapeutic Delivery2019102
38Viral vectors and delivery strategies for CNS gene therapyTherapeutic Delivery2010101
39Local drug delivery to the bone by drug-releasing implants: perspectives of nano-engineered titania nanotube arraysTherapeutic Delivery201299
40Pathways and progress in improving drug delivery through the intestinal mucosa and blood–brain barriersTherapeutic Delivery201499
41Delivery and targeting of nanoparticles into hair folliclesTherapeutic Delivery201498
42Therapeutic nanomedicine for brain cancerTherapeutic Delivery201397
43The PulmoSphere™ platform for pulmonary drug deliveryTherapeutic Delivery201497
44Potential enhancement and targeting strategies of polymeric and lipid-based nanocarriers in dermal drug deliveryTherapeutic Delivery201795
45Nanoemulsion-based oral delivery systems for lipophilic bioactive components: nutraceuticals and pharmaceuticalsTherapeutic Delivery201394
46Nanocarrier fabrication and macromolecule drug delivery: challenges and opportunitiesTherapeutic Delivery201694
47Mesh nebulizers have become the first choice for new nebulized pharmaceutical drug developmentsTherapeutic Delivery201893
48Delivery of drugs bound to erythrocytes: new avenues for an old intravascular carrierTherapeutic Delivery201591
49Current progress on aptamer-targeted oligonucleotide therapeuticsTherapeutic Delivery201390
50Molecular determinants of blood–brain barrier permeationTherapeutic Delivery201589